In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, Eris Lifesciences has informed that the company will meet Analyst / Institutional Investor in a ‘IIFL’s 16th Enterprising India Conference 2025’ on 18th February, 2025 on a One to One basis. The company will be referring to publicly available documents for discussions during interaction in the meeting and no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.
The above information is a part of company’s filings submitted to BSE.
